BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ONO-2020 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ONO-2020\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06803823-772@assetmemo.bio
DTSTAMP:20261121T005826Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:ONO-2020: Phase 2 readout est. (NCT06803823)
DESCRIPTION:ONO-2020\, phase 2\, Alzheimer's Disease.\nStudy: A Study of ON
 O-2020 in Patients With Agitation Associated With Alzheimer's Disease Deme
 ntia\nEstimated primary completion: 31 December 2026. This is a ClinicalTr
 ials.gov estimate\, not a confirmed readout date\, and it can move.\nDrug 
 page: https://assetmemo.bio/drug/ono-2020#upcoming-events\nRegistry record
 : https://clinicaltrials.gov/study/NCT06803823
URL:https://assetmemo.bio/drug/ono-2020#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
